Moderna asks US, European regulators, to allow emergency use of COVID-19 vaccine

New York: Moderna Inc on Monday (November 30) said that it would ask the United States and European regulators to allow emergency use of its COVID-19 vaccine as new study results confirm the shots offer strong protection ramping up the race to begin limited vaccinations as the coronavirus rampage worsens. Multiple vaccine candidates must succeed … Read more

COVID-19: Sputnik V developer says its vaccine cheaper than Pfizer, Moderna – Check prices here

The developer of Sputnik V have claimed that the price of the Russian coronavirus vaccine Sputnik V will be lower than the vaccine developed by Pfizer and Moderna. “Translating pharma lingo: the announced price of Pfizer of USD 19.50 (Rs 1446) and Moderna of USD 25-USD 37 (Rs 1854.07-2744.02) per dose actually means their price … Read more

Moderna to charge Rs 1855-Rs 2755 for COVID-19 vaccine: CEO

The Chief Executive of Moderna, Stephane Bancel, on Saturday said that his company will charge governments between Rs 1855 (USD 25) and Rs 2755 (USD 37) per dose of its COVID-19 vaccine candidate. Talking to German weekly Welt am Sonntag (WamS), Barcel said that the price of the coronavirus vaccine will depend on the amount … Read more

Moderna says its vaccine is 94.5% effective in preventing COVID-19

Moderna Inc`s experimental vaccine was 94.5% effective in preventing COVID-19 based on interim data from a late-stage trial, the company said on Monday, becoming the second U.S. drugmaker to report results that far exceed expectations. Together with Pfizer Inc`s vaccine, which is also more than 90% effective, and pending more safety data and regulatory review, … Read more

Good news! After Pfizer, now this company gets closer to announce results of COVID-19 vaccine

Amid rising coronavirus COVID-19 cases across the world, US-based biotechnology firm Moderna is getting closer to release¬† data on its late-stage trials of the coronavirus vaccine candidate. Moderna has announced that it has collected enough data for an interim analysis of the late-stage trial of its coronavirus vaccine, adding that the analysis of the data … Read more